Biomea Fusion moves BMF-650 Phase I topline readout to October 2026

Biomea Fusion, Inc.

Company now expects topline results for BMF-650 Phase I (GLP-131) in October 2026.
Trial enrolls obese, otherwise healthy volunteers; no results disclosed yet.
Timing update issued September 22, 2026; prior expectation unspecified.

item 8.01

Biomea Fusion, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-397870

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.